I. Introduction
Renal cell carcinoma (RCC) is one of the most common types of renal cancer, accounting for 80% of early renal cancer, which is the third most common urological tumor after prostate cancer, and bladder cancer [1]. With the development of medical imaging, the detection rate of early kidney cancer has increased. The most common histopathological type of renal cell carcinoma is clear cell carcinoma (ccRCC), papillary renal cell carcinoma (pRCC), and chromophobe cell carcinoma (chRCC) [2]. In the pathological diagnosis, the subtypes and grades are the critical diagnostic results, different subtypes of renal cell carcinoma can be treated with different regimens (including chemotherapy and targeted therapy), the higher the grading, the worse the prognosis, the greater the possibility of recurrence and tumor metastasis, and the faster the course of the disease.